Breakthrough Technology Reveals New Treatment Targets for Cancer

Researchers published Nature study on PerturbFate, a single-cell platform that tracks DNA accessibility and RNA changes to follow how genetic perturbations reshape cells over time.

In melanoma drug-resistance experiments, the platform showed that different mutations can converge on the same cellular programs and regulatory nodes.

The finding points to shared downstream control points as potential drug targets, even across genetically diverse cancers.

The approach could streamline drug development by targeting common mechanisms rather than each mutation separately.